Next-Generation Sequencing (NGS) Services by Type (Targeted Sequencing, Whole Exome Sequencing, Whole Genome Sequencing), by Application (Hospitals and Clinics, Biopharma Companies, Academic & Research Organizations, Others), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast 2026-2034
MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.
Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.
The Next-Generation Sequencing (NGS) services market is experiencing robust growth, projected to reach a substantial size driven by several key factors. The market's Compound Annual Growth Rate (CAGR) of 15% from 2019 to 2024 indicates a strong upward trajectory. This expansion is fueled by the increasing adoption of NGS technologies across diverse applications, including oncology, genetic disease diagnostics, pharmacogenomics, and infectious disease research. The rising prevalence of chronic diseases, the growing demand for personalized medicine, and advancements in sequencing technologies are key drivers. The market is segmented by sequencing type (Targeted, Whole Exome, Whole Genome) and application (Hospitals & Clinics, Biopharma Companies, Academic & Research Organizations). The significant presence of established players like Illumina, Roche, and Eurofins Scientific, alongside emerging companies like Natera and Personalis, indicates a competitive yet innovative landscape. Geographic expansion, particularly in rapidly developing economies of Asia-Pacific and regions with increasing healthcare investments, further contributes to the market's growth. While data limitations prevent precise numerical projections, the sustained high CAGR and market dynamics suggest substantial future expansion.
Next-Generation Sequencing (NGS) Services Market Size (In Billion)
40.0B
30.0B
20.0B
10.0B
0
13.32 B
2025
15.33 B
2026
17.65 B
2027
20.30 B
2028
23.34 B
2029
26.80 B
2030
30.71 B
2031
The dominance of North America, attributed to advanced healthcare infrastructure and high research spending, is expected to continue. However, the Asia-Pacific region is poised for significant growth, driven by increasing healthcare expenditure and rising awareness of genetic testing. Europe maintains a substantial market share, with continued investment in genomics research and healthcare innovation. The market faces certain restraints, primarily related to high costs associated with NGS services and the need for skilled professionals to analyze the complex data generated. However, ongoing technological advancements, such as the development of more cost-effective sequencing platforms and user-friendly analytical tools, are mitigating these challenges. The increasing accessibility of NGS services through collaborations between public and private sectors is further expanding market reach and accessibility. The market's future hinges on the continued development of innovative applications, such as liquid biopsy for cancer detection, and the expansion of NGS into new clinical and research areas.
Next-Generation Sequencing (NGS) Services Company Market Share
Loading chart...
Next-Generation Sequencing (NGS) Services Trends
The global next-generation sequencing (NGS) services market is experiencing explosive growth, projected to reach multi-billion dollar valuations by 2033. Driven by advancements in technology, decreasing costs, and a broadening range of applications, the market witnessed significant expansion during the historical period (2019-2024). The estimated market value in 2025 is in the several billion dollar range, with a strong forecast for continued expansion throughout the forecast period (2025-2033). Key market insights reveal a shift towards higher-throughput sequencing technologies, increasing adoption in personalized medicine, and a growing demand for comprehensive NGS services encompassing everything from sample preparation to data analysis. This trend is fueled by the increasing recognition of NGS’s role in various fields, including oncology, infectious disease diagnostics, pharmacogenomics, and agricultural biotechnology. The market's competitive landscape is characterized by a mix of large multinational corporations and smaller specialized providers, each vying for market share through technological innovation and strategic partnerships. The increasing accessibility of NGS technology to a broader range of users, including smaller research institutions and clinics, is also a key trend shaping the market's growth trajectory. The integration of artificial intelligence (AI) and machine learning (ML) in data analysis is further accelerating the adoption of NGS, enabling faster, more accurate, and insightful results. This leads to more efficient workflows and the ability to handle larger volumes of data generated by the increasingly sophisticated NGS platforms. The market is also witnessing a growing demand for cloud-based NGS data analysis platforms, offering scalability and cost-effectiveness to researchers and clinicians alike.
Driving Forces: What's Propelling the Next-Generation Sequencing (NGS) Services Market?
Several key factors are driving the rapid expansion of the NGS services market. The plummeting cost of sequencing is a primary driver, making NGS accessible to a wider range of users and applications. Simultaneously, technological advancements continue to improve sequencing speed, accuracy, and throughput. This allows for the analysis of larger and more complex genomes, unlocking new opportunities in research and diagnostics. The rising prevalence of chronic diseases, including cancer, necessitates the development of personalized medicine approaches, where NGS plays a crucial role in identifying individual genetic variations that influence disease susceptibility and treatment response. Furthermore, the increasing focus on early disease detection and preventative medicine is boosting demand for NGS-based diagnostic tests. The growing adoption of NGS in pharmaceutical research and development (R&D) to accelerate drug discovery and development processes further fuels market growth. Biopharmaceutical companies are leveraging NGS to identify novel drug targets, develop companion diagnostics, and personalize treatment strategies. Finally, increased government funding for genomics research and initiatives promoting precision medicine are creating a favorable environment for the growth of the NGS services market. This combined effect of technological advancements, cost reduction, and growing application areas is driving the unprecedented growth observed in the sector.
Challenges and Restraints in Next-Generation Sequencing (NGS) Services
Despite the remarkable growth, the NGS services market faces several challenges. Data analysis and interpretation remain significant hurdles. The massive datasets generated by NGS require sophisticated bioinformatics tools and expertise, posing a bottleneck for many users. The need for skilled professionals capable of handling data analysis and interpretation creates a shortage in the workforce. This lack of expertise can limit the adoption of NGS in some settings. Data privacy and security are also critical concerns, especially as NGS generates sensitive personal genetic information. Robust data security measures and ethical guidelines are essential for protecting patient privacy and maintaining public trust. Furthermore, regulatory approvals and reimbursement policies can vary across different regions and countries, creating complexities and uncertainties for providers of NGS services. The high initial investment costs associated with acquiring and maintaining NGS equipment and infrastructure can also pose a barrier to entry for some smaller companies or institutions. Finally, the need for standardized protocols and data formats is crucial for ensuring interoperability and comparability of results across different platforms and laboratories.
Key Region or Country & Segment to Dominate the Market
The North American market, particularly the United States, is currently dominating the NGS services market, driven by the presence of major players, robust research infrastructure, and high healthcare expenditure. However, the Asia-Pacific region is projected to experience the fastest growth rate during the forecast period, fueled by increasing government investments in healthcare infrastructure, rising awareness of genetic testing, and a burgeoning biopharmaceutical industry.
Dominant Segments:
Whole Exome Sequencing (WES): WES is experiencing strong growth due to its cost-effectiveness compared to whole-genome sequencing while still providing comprehensive information on protein-coding genes. It is widely used in various applications including diagnostic testing for genetic disorders, pharmacogenomics, and cancer research.
Application: Biopharma Companies: This segment is a significant contributor to market growth due to the increasing use of NGS in drug discovery, development, and personalized medicine. Biopharma companies are heavily investing in NGS-based research to identify new drug targets, develop companion diagnostics, and optimize clinical trials. The ability to analyze large datasets of patient genomic data enables the development of targeted therapies and predictive biomarkers.
In paragraph form:
The North American market, led by the US, holds a significant share of the NGS services market due to the presence of major players like Illumina and Roche, strong research infrastructure, high healthcare expenditure, and early adoption of NGS technologies. This region boasts a well-established regulatory framework and robust reimbursement policies supporting the widespread use of NGS in clinical diagnostics and research. However, the Asia-Pacific region is expected to witness the most rapid growth in the coming years. Factors such as rising healthcare expenditure, increasing government initiatives promoting genomic research, a burgeoning biopharmaceutical industry, and a growing understanding of the benefits of personalized medicine are fueling this expansion. Within the segments, Whole Exome Sequencing (WES) is a prominent driver due to its cost-effectiveness and comprehensive coverage of protein-coding genes, making it suitable for various applications. The Biopharma segment is particularly lucrative, with companies leveraging NGS for drug discovery, development of companion diagnostics, and personalized treatment strategies. The ability to screen for variations across large cohorts and link them to clinical outcomes significantly accelerates and improves drug development.
Growth Catalysts in Next-Generation Sequencing (NGS) Services Industry
The NGS services industry is propelled by several key growth catalysts, including the falling cost of sequencing, technological advancements leading to faster and more accurate sequencing, the rising adoption of personalized medicine, the increasing prevalence of chronic diseases, and the growing demand for early disease detection and preventative healthcare measures. Further fueling growth is the increased investment in genomics research from governments and the private sector, expanding applications in diverse fields like oncology, infectious diseases, and agriculture.
Leading Players in the Next-Generation Sequencing (NGS) Services
This report provides a comprehensive analysis of the next-generation sequencing (NGS) services market, covering market trends, driving forces, challenges, key players, and significant developments. It offers detailed insights into market segmentation by sequencing type (targeted sequencing, whole exome sequencing, whole genome sequencing) and application (hospitals and clinics, biopharma companies, academic & research organizations, others). The report provides valuable information for stakeholders including companies, investors, and researchers seeking to understand the dynamics and future prospects of this rapidly evolving market. The market forecasts and detailed analysis presented provide a clear understanding of the significant opportunities within the NGS services sector.
Table 46: Rest of Asia Pacific Next-Generation Sequencing (NGS) Services Revenue (million) Forecast, by Application 2020 & 2033
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segments, product, and application.
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
Web Analytics
Survey Reports
Research Institute
Latest Research Reports
Opinion Leaders
Secondary Research
Annual Reports
White Paper
Latest Press Release
Industry Association
Paid Database
Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
Additionally, after gathering mixed and scattered data from a wide range of sources, data is triangulated and correlated to come up with estimated figures which are further validated through primary mediums or industry experts, opinion leaders.
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Next-Generation Sequencing (NGS) Services?
The projected CAGR is approximately 15.0%.
2. Which companies are prominent players in the Next-Generation Sequencing (NGS) Services?
Key companies in the market include Eurofins Scientific, Natera, BGI, Illumina, Roche, LabCorp, Berry Genomics, Brooks Life Sciences, Macrogen, Personalis, Novogene, Genotypic Technology, Dna Link.
3. What are the main segments of the Next-Generation Sequencing (NGS) Services?
The market segments include Type, Application.
4. Can you provide details about the market size?
The market size is estimated to be USD 13320 million as of 2022.
5. What are some drivers contributing to market growth?
N/A
6. What are the notable trends driving market growth?
N/A
7. Are there any restraints impacting market growth?
N/A
8. Can you provide examples of recent developments in the market?
N/A
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3480.00, USD 5220.00, and USD 6960.00 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Next-Generation Sequencing (NGS) Services," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Next-Generation Sequencing (NGS) Services report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Next-Generation Sequencing (NGS) Services?
To stay informed about further developments, trends, and reports in the Next-Generation Sequencing (NGS) Services, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
-Services.png&w=1920&q=75)
-Services.png&w=1920&q=75)
-Services.png&w=1920&q=75)
Next-Generation Sequencing (NGS) Services